Brushing up on the state of healthcare price transparency in 2025

A summary of recent initiatives to promote healthcare price transparency in 2025, why they risk being insufficiently effective, and what supplementary efforts might be needed to empower consumers and bring costs down.

Marina Renton
Marina Renton
Updated Aug 13, 2025 11 min read

The push toward healthcare price transparency started in earnest nearly 15 years ago, when the ACA highlighted the need for greater insight into hospital pricing, and the premise of healthcare consumerism took hold alongside the rise of high-deductible health plans. And while it’s no longer the headline-grabber it once was, healthcare price transparency remains a perennial topic of discussion—and debate—within the industry. It’s also a good topic to revisit periodically precisely because it no longer dominates the headlines, even as progress continues quietly below the surface.

While opinions on many health care policy topics are divided along party lines (see the intense debate and negotiation prior to the passage of the OBBBA, about which you can read more here), price transparency tends to garner bipartisan support. And it thus remains a steady target of reforms. In just the latest example, on July 17, Senators Robert Marshall (R-Kansas) and John Hickenlooper (D-Colorado) introduced the Patients Deserve Price Tags Act, which would require hospitals, ambulatory surgery centers, imaging centers, and labs to publicly report prices, negotiated rates, and costs for their services.

On the surface, the bipartisan appeal makes sense. Healthcare price transparency is a free market-friendly, light political lift (in the sense that it doesn’t require huge amounts of new regulation), very American approach. In theory, price transparency enhances competition in healthcare by empowering consumers to shop for care and, in so doing, encouraging price convergence and competition.

Let’s talk.

Questions? Want to learn more about what Union can do for you? We’d love to hear from you.